Analytical and clinical performance of NT-proBNP immunoassay.

被引:0
|
作者
Zucchelli, G [1 ]
Prontera, C [1 ]
Ripoli, A [1 ]
Emdin, M [1 ]
Iervasi, A [1 ]
Passino, C [1 ]
Mercuri, A [1 ]
Clerico, A [1 ]
机构
[1] CNR, Ist Fisiol Clin, I-56100 Pisa, Italy
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:A37 / A37
页数:1
相关论文
共 50 条
  • [41] The Ability of Heart Failure Specialists to Accurately Predict NT-proBNP Levels Based on Clinical Assessment and a Previous NT-proBNP Measurement
    Sedlak, Tara L.
    Chandavimol, Mann
    Calleja, Anna
    Clark, Catherine
    Edmonds, Margaret
    Pu, Aihua
    Humphries, Karin H.
    Ignaszewski, Andrew
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2008, 2 : 36 - 40
  • [42] NT-proBNP, to be or not to be a BPD biomarker?
    Danhaive, Olivier
    Hocq, Catheline
    PEDIATRIC RESEARCH, 2024,
  • [43] NT-proBNP in Cardioembolic Stroke
    Sethi, Prahlad K.
    Rajeswari, R.
    Sethi, Nitin K.
    NEUROLOGY INDIA, 2023, 71 (04) : 866 - 867
  • [44] NT-proBNP: note ethnicity!
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (12) : 735 - 735
  • [45] The biomarkers BNP and NT-proBNP
    Oremek, G. M.
    Passek, K.
    Holzgreve, F.
    von der Eltz, V.
    Droege, J.
    ZENTRALBLATT FUR ARBEITSMEDIZIN ARBEITSSCHUTZ UND ERGONOMIE, 2023, 73 (02): : 89 - 95
  • [46] Analytical Characterization of a Novel NT-proBNP Assay on a Central Laboratory Platform
    Christenson, R. H.
    Alahapperuma, D.
    Allen, B. R.
    Guidi, J. L.
    Headden, G.
    Peacock, W. F.
    Winden, N.
    Januzzi, J. L.
    CLINICAL CHEMISTRY, 2024, 70
  • [47] Placental Expression of proBNP/NT-proBNP and Plasma Levels of NT-proBNP in Early- and Late-Onset Preeclampsia
    Junus, Katja
    Wikstrom, Anna-Karin
    Larsson, Anders
    Olovsson, Matts
    AMERICAN JOURNAL OF HYPERTENSION, 2014, 27 (09) : 1225 - 1230
  • [48] Analytical performance evaluation of the Bayer Advia Centaur BNP immunoassay.
    Smith, AC
    Wu, AH
    CLINICAL CHEMISTRY, 2003, 49 (06) : A71 - A71
  • [49] Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
    Cardoso Curiati, Milena Novaes
    Silvestre, Odilson Marcos
    Tachotti Pires, Lucas Jose
    Mangini, Sandrigo
    Pires, Philippe Vieira
    Gaiotto, Fabio Antonio
    Laurino, Andre Micheletto
    Pego-Fernandes, Paulo Manuel
    dos Santos Ferreira, Carlos Eduardo
    Bacal, Fernando
    EINSTEIN-SAO PAULO, 2013, 11 (03): : 273 - 277
  • [50] Sense and Sensibility of the Use of NT-proBNP for Eligibility in Clinical Trials
    Voors, Adriaan A.
    JACC-HEART FAILURE, 2018, 6 (03) : 257 - 259